Testing a new cholesterol medication combination for diabetes patients

This study is testing whether Ezefeno Tab.—a combination medication containing ezetimibe and fenofibrate—works better when taken alongside a moderate-dose statin compared to simply taking a higher dose of statin alone. The trial focuses on people with type 2 diabetes whose cholesterol levels remain too high even on a moderate dose of statin. Researchers want to see if this medication combination can help control cholesterol more effectively and safely over the long term.

Many people with type 2 diabetes struggle to control their cholesterol even when taking a moderate dose of statin medication. This study exists to see whether adding this medication can provide better control without requiring higher and potentially less safe doses of statin.